cerca CERCA
Venerdì 30 Luglio 2021
Aggiornato: 19:34
Temi caldi

Salute_E_Benessere Chimica_E_Farmacia Salute_E_Benessere Salute_E_Benessere

EpiVax Announces Participation in International Consortium for Development of Next-Generation Influenza Vaccines (INDIGO)

PROVIDENCE, R.I., Feb. 17, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") today announces its participation in the INDIGO consortium – a partnership of public and private research and development organizations from the EU, India, and United States (funded by the EU and India) with the aim of developing next-generation influenza vaccines with better responsiveness, lower costs, and better accessibility.

Vexos receives Health Canada Approval for the MVM Ventilator

TORONTO, Sept. 30, 2020 /PRNewswire/ -- Vexos Inc., a Global Electronics Manufacturing Services provider, is pleased to announce that Health Canada has approved the Mechanical Ventilator Milano (MVM) ventilator for use under Interim Order. In May, Vexos signed a contract with the Government of Canada to manufacture and supply 10,000 MVM units as part of the national mobilization to combat the Covid-19 pandemic. 

ora in
Prima pagina
in Evidenza